Page 3 - Afirma Genomic Sequencing Classifier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Afirma genomic sequencing classifier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Afirma Genomic Sequencing Classifier Today - Breaking & Trending Today

Veracyte (VCYT) Scheduled to Post Quarterly Earnings on Tuesday

Veracyte (NASDAQ:VCYT – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.19) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link. Veracyte (NASDAQ:VCYT – Get […] ....

United States , Karin Eastham , William Blair , Securities Exchange Commission , Morgan Stanley , Goldman Sachs Group , Veracyte Inc , Needham Company , Veracyte Company Profile , Get Free Report , Trading Down , Director Karin Eastham , Exchange Commission , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test , Envisia Genomic Classifier , Veracyte Daily ,

Sumitomo Mitsui Trust Holdings Inc. Cuts Position in Veracyte, Inc. (NASDAQ:VCYT)

Sumitomo Mitsui Trust Holdings Inc. cut its stake in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 2.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,104,676 shares of the biotechnology company’s stock after selling 68,900 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about […] ....

United States , William Blair , Karin Eastham , Morgan Stanley , Investment Management , Veracyte Inc , Needham Company , Invesco Ltd , Blackrock Inc , Sumitomo Mitsui Trust Holdings Inc , Securities Exchange Commission , Vanguard Group Inc , Goldman Sachs Group , Sumitomo Mitsui Trust Holdings , Free Report , Mitsui Trust Holdings , Street Corp , Director Karin Eastham , Exchange Commission , Trading Down , Get Free Report , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test ,

Veracyte, Inc. (NASDAQ:VCYT) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have been assigned an average rating of “Moderate Buy” from the five ratings firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. The average 12 […] ....

Hong Kong , United States , William Blair , International Assets Investment Management , Morgan Stanley , Needham Company , Veracyte Inc , Russell Investments Group Ltd , Veracyte Company Profile , Hong Kong Ltd , China Universal Asset Management Co , Get Free Report , Investments Group , Kong Ltd , Assets Investment Management , Universal Asset Management , Trading Down , Get Free , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test , Envisia Genomic Classifier , Veracyte Daily ,

Veracyte (NASDAQ:VCYT) Rating Reiterated by William Blair

William Blair reiterated their outperform rating on shares of Veracyte (NASDAQ:VCYT – Free Report) in a research report sent to investors on Friday, RTT News reports. William Blair also issued estimates for Veracyte’s Q2 2025 earnings at ($0.01) EPS and FY2025 earnings at $0.00 EPS. A number of other brokerages have also issued reports on […] ....

Hong Kong , William Blair , Russell Investments Group Ltd , Veracyte Inc , Needham Company , International Assets Investment Management , Morgan Stanley , China Universal Asset Management Co , Hong Kong Ltd , Veracyte Company Profile , Free Report , Moderate Buy , Investments Group , Kong Ltd , Assets Investment Management , Universal Asset Management , Get Free Report , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test , Envisia Genomic Classifier , Immunoscore Colon Cancer , Veracyte Daily , Nasdaq Vcyt ,

Needham & Company LLC Boosts Veracyte (NASDAQ:VCYT) Price Target to $33.00

Veracyte (NASDAQ:VCYT – Get Free Report) had its price target lifted by Needham & Company LLC from $30.00 to $33.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s price target suggests a potential upside of 35.58% from the […] ....

William Blair , Veracyte Inc , China Universal Asset Management Co , Morgan Stanley , Needham Company , Legato Capital Management , York Mellon Corp , Assetmark Inc , Get Free Report , Trading Down , Universal Asset Management , Capital Management , New York Mellon Corp , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test , Envisia Genomic Classifier , Immunoscore Colon Cancer , Veracyte Daily , Nasdaq Vcyt , Boost Price Target , Needham Amp Company Llc ,